Attached files

file filename
EX-31.01 - EX-31.01 - INVO Bioscience, Inc.ex31-01.htm
EX-32.01 - EX-32.01 - INVO Bioscience, Inc.ex32-01.htm
EX-31.02 - EX-31.02 - INVO Bioscience, Inc.ex31-02.htm
EX-21.01 - EX-21.01 - INVO Bioscience, Inc.ex21-01.htm
10-K - 10-K - INVO Bioscience, Inc.invobio10k123116.htm

Certification by the Principal Financial Officer Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Robert J. Bowdring, certify pursuant to 18 U. S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the Annual Report on Form 10-K of INVO Bioscience, Inc. (the “Company”) for the year ended December 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 20, 2017
/s/ Robert J. Bowdring
Robert J. Bowdring
Acting Chief Financial Officer

A signed original copy of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.